Tech Focus Asia
SEE OTHER BRANDS

Fresh science and technology news from Asia and the Pacific

Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on September 17, 2025

Simon S. James Expands Global Influence with Strategic Engagements Across Six Continents
Machine Vision Products Unveils New Homepage at Visionpro.com
Học Viện Lạc Hồng Agent (HVLH) triển khai ba hoạt động hỗ trợ giáo dục và cứu trợ sau thiên tai tại Điện Biên
Nearsite secures Mentors Fund investment to accelerate AI innovation in workforce and insurance housing procurement
ConnectM Announces Q2 2025 Results and Form 10‑Q Filing; Strong Execution Across Segments
Tesla Mechanical Designs Blends Engineering and Aesthetics with Advanced 3D Modeling and Precision Sheet Metal Services
IndoUSrare Announces 2025 Abbey Meyers Khushi Bridging RARE Award Honorees
ChowChow Cloud Announces Pricing of Initial Public Offering
North America Internet of Things Devices Market Projected to $88.07+ Billion Market Value by 2030 with a 14.86% CAGR
عدد مستخدمي منصة PartyPlatform الإماراتية يصل إلى 10,000 مستخدم، ما يُحدث تحولًا في قطاع تنظيم الفعاليات بالإمارات من خلال سوقٍ أكثر ذكاءً
Lithium Chile Announces Life Offering of Up to $5,000,000
Xcite Resources Announces Concurrent Brokered Life Offering & Flow-Through Shares Private Placement Alongside Amending Agreements Respecting Athabasca Uranium Portfolio
Fanspicy Announces Expanded Payment Solutions for Creators
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Silicon Valley Certification Hub Records 30% QoQ Revenue Growth as Demand for AI Certification Accelerates
Mawson Infrastructure Group Inc. Shares Corporate Update
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Red Cat Holdings Announces Proposed Public Offering of Common Stock
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions